TrialJAMA cardiology2025

Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial.

Alexis Hure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.